Epigenetic subgroups of esophageal and gastric adenocarcinoma with differential GATA5 DNA methylation associated with clinical and lifestyle factors

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Wang, Xinhui ^a   Kang, Gyeong Hoon ^b   Campan, Mihaela ^a   Weisenberger, Daniel J ^d   Long, Tiffany I ^a   Cozen, Wendy ^a   Bernstein, Leslie ^c   Wu, Anna H ^a   Siegmund, Kimberly D ^a   Shibata, Darryl ^a   Laird, Peter W ^a,d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Seoul National University College of Medicine   (South Korea)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER; TRANSCRIPTION FACTOR GATA 5;

ADULT; ARTICLE; BODY MASS; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; CONTROLLED STUDY; DNA DETERMINATION; DNA METHYLATION; EPIGENETICS; ESOPHAGEAL ADENOCARCINOMA; FEMALE; GASTROESOPHAGEAL REFLUX; GATA5 GENE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC MARKER; GENETIC RISK; HUMAN; HUMAN TISSUE; LONG TERM EXPOSURE; MALE; OUTCOME ASSESSMENT; PREDICTION; RISK ASSESSMENT; SEDENTARY LIFESTYLE; SEX DIFFERENCE; SMOKING HABIT; STOMACH ADENOCARCINOMA; SURVIVAL TIME; TUMOR DIFFERENTIATION; TUMOR GENE; ADENOCARCINOMA; CASE CONTROL STUDY; CLUSTER ANALYSIS; ESOPHAGUS TUMOR; GENETIC EPIGENESIS; GENETICS; LIFESTYLE; MIDDLE AGED; PATHOLOGY; RISK FACTOR; STOMACH TUMOR; SURVIVAL;

ADENOCARCINOMA; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; DNA METHYLATION; EPIGENESIS, GENETIC; ESOPHAGEAL NEOPLASMS; FEMALE; GATA5 TRANSCRIPTION FACTOR; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; RISK FACTORS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 80054785997     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025985     Document Type: Article

References (42)

1. Jones PA, Laird PW, (1999) Cancer epigenetics comes of age. Nat Genet 21: 163-167.
2. Jones PA, Baylin SB, (2007) The epigenomics of cancer. Cell 128: 683-692.
3. Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, et al. (2007) Epigenetic stem cell signature in cancer. Nat Genet 39: 157-158.
4. Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, et al. (2007) A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 39: 237-242.
5. Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, et al. (2007) Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 39: 232-236.
6. Laird PW, (2003) The power and the promise of DNA methylation markers. Nat Rev Cancer 3: 253-266.
7. Lagarde SM, ten Kate FJ, Reitsma JB, Busch OR, van Lanschot JJ, (2006) Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol 24: 4347-4355.
8. Devesa SS, Silverman DT, Young JL Jr, Pollack ES, Brown CC, et al. (1987) Cancer incidence and mortality trends among whites in the United States, 1947-84. J Natl Cancer Inst 79: 701-770.
9. Brown LM, Devesa SS, Chow WH, (2008) Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 100: 1184-1187.
10. Lagergren J, Bergstrom R, Lindgren A, Nyren O, (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340: 825-831.
11. Devesa SS, Blot WJ, Fraumeni JF Jr, (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83: 2049-2053.
12. Wu H, Rusiecki JA, Zhu K, Potter J, Devesa SS, (2009) Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev 18: 1945-1952.
13. MacDonald WC, MacDonald JB, (1987) Adenocarcinoma of the esophagus and/or gastric cardia. Cancer 60: 1094-1098.
14. Crane SJ, Locke GR 3rd, Harmsen WS, Diehl NN, Zinsmeister AR, et al. (2007) Subsite-specific risk factors for esophageal and gastric adenocarcinoma. Am J Gastroenterol 102: 1596-1602.
15. Siewert JR, Stein HJ, (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85: 1457-1459.
16. Eads CA, Lord RV, Kurumboor SK, Wickramasinghe K, Skinner ML, et al. (2000) Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res 60: 5021-5026.
17. Eads CA, Lord RV, Wickramasinghe K, Long TI, Kurumboor SK, et al. (2001) Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res 61: 3410-3418.
18. Kawakami K, Brabender J, Lord RV, Groshen S, Greenwald BD, et al. (2000) Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J Natl Cancer Inst 92: 1805-1811.
19. Sato F, Meltzer SJ, (2006) CpG island hypermethylation in progression of esophageal and gastric cancer. Cancer 106: 483-493.
20. Yamamoto E, Suzuki H, Takamaru H, Yamamoto H, Toyota M, et al. (2011) Role of DNA methylation in the development of diffuse-type gastric cancer. Digestion 83: 241-249.
21. Alvarez H, Opalinska J, Zhou L, Sohal D, Fazzari MJ, et al. (2011) Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis. PLoS Genet 7: e1001356.
22. Wu AH, Wan P, Bernstein L, (2001) A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States). Cancer Causes Control 12: 721-732.
23. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, et al. (2005) Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 33: 6823-6836.
24. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, et al. (2000) MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28: E32.
25. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, et al. (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38: 787-793.
26. Ward JH, (1963) Hierarchical Grouping to Optimize an Objective Function. Journal of the American Statistical Association 58: 236.
27. Benjamini Y, Hochberg Y, (1995) Controlling the False Discovery Rate- a Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B-Methodological 57: 289-300.
28. Kang GH, Lee S, Cho NY, Gandamihardja T, Long TI, et al. (2008) DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis. Lab Invest 88: 161-170.
29. Widschwendter M, Siegmund KD, Muller HM, Fiegl H, Marth C, et al. (2004) Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen. Cancer Res 64: 3807-3813.
30. Guo M, House MG, Akiyama Y, Qi Y, Capagna D, et al. (2006) Hypermethylation of the GATA gene family in esophageal cancer. Int J Cancer 119: 2078-2083.
31. Akiyama Y, Watkins N, Suzuki H, Jair KW, van Engeland M, et al. (2003) GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Mol Cell Biol 23: 8429-8439.
32. Fu B, Guo M, Wang S, Campagna D, Luo M, et al. (2007) Evaluation of GATA-4 and GATA-5 methylation profiles in human pancreatic cancers indicate promoter methylation patterns distinct from other human tumor types. Cancer Biol Ther 6: 1546-1552.
33. Guo M, Akiyama Y, House MG, Hooker CM, Heath E, et al. (2004) Hypermethylation of the GATA genes in lung cancer. Clin Cancer Res 10: 7917-7924.
34. Wakana K, Akiyama Y, Aso T, Yuasa Y, (2006) Involvement of GATA-4/-5 transcription factors in ovarian carcinogenesis. Cancer Lett 241: 281-288.
35. Leng S, Stidley CA, Willink R, Bernauer A, Do K, et al. (2008) Double-strand break damage and associated DNA repair genes predispose smokers to gene methylation. Cancer Res 68: 3049-3056.
36. Lyon CM, Klinge DM, Liechty KC, Gentry FD, March TH, et al. (2007) Radiation-induced lung adenocarcinoma is associated with increased frequency of genes inactivated by promoter hypermethylation. Radiat Res 168: 409-414.
37. Furniss CS, Marsit CJ, Houseman EA, Eddy K, Kelsey KT, (2008) Line region hypomethylation is associated with lifestyle and differs by human papillomavirus status in head and neck squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 17: 966-971.
38. Arasaradnam RP, Commane DM, Bradburn D, Mathers JC, (2008) A review of dietary factors and its influence on DNA methylation in colorectal carcinogenesis. Epigenetics 3: 193-198.
39. Kimmons JE, Blanck HM, Tohill BC, Zhang J, Khan LK, (2006) Associations between body mass index and the prevalence of low micronutrient levels among US adults. MedGenMed 8: 59.
40. Lagergren J, (2006) Controversies surrounding body mass, reflux, and risk of oesophageal adenocarcinoma. Lancet Oncol 7: 347-349.
41. Spechler SJ, Goyal RK, (1986) Barrett's esophagus. N Engl J Med 315: 362-371.
42. DeMeester SR, DeMeester TR, (2000) Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg 231: 303-321.